Truist lowered the firm’s price target on Stryker (SYK) to $392 from $407 and keeps a Hold rating on the shares. The company delivered a small revenue beat with mixed quality earnings upside that was driven by non-op items and tax, which offset a slight operating margin miss, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker Corp’s Earnings Call Highlights Robust Growth
- Stryker’s Mixed Performance and Valuation Concerns Justify Hold Rating with Adjusted Price Target
- Stryker price target lowered to $392 from $407 at Truist
- Stryker’s Strong Q3 Performance and Raised Guidance Justify Buy Rating
- Stryker price target lowered to $405 from $410 at Evercore ISI